Delivery Order SPE2DB24D9144-SPE2DB25FCMZA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. on August 5, 2025, for the supply of YF-VAX 1 dose vials with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a straightforward pharmaceutical procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials on August 20, 2025. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 11, 2025, with performance taking place in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, will supply the yellow fever vaccine vials to support federal healthcare needs....
- The Defense Logistics Agency awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, a yellow fever vaccine product. The contract, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, operates under a firm fixed-price structure with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Illinois...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order employs firm fixed-price terms and represents a standard procurement action within the agency's pharmaceutical supply operations....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, a $499.9 billion contract vehicle valid through November 2026 that enables the agency to procure pharmaceutical products and medical supplies for...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. This delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, carries no set-aside designation. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. on August 19, 2025, for the provision of YF-VAX 1 dose vials, a yellow fever vaccine product. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, was issued without a set-aside designation. Performance will take place at DMS Pharmaceutical Group's facility in Park Ridge, Illinois. The contract represents a discrete fulfillment under DMS...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,783.55 by the Defense Logistics Agency on July 25, 2025, for YF-VAX 1 dose vials. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a discrete procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $2,226.84 for YF-VAX 1 dose vials with an ultimate completion date of August 26, 2025. This delivery order was issued without a set-aside designation and represents a discrete procurement action under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at...
- SPE2DB24D9144Indefinite Delivery Contract
- SPE2DB24D9144-SPE2DB25FCMZADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials on August 28, 2025. This firm fixed-price delivery order, which is expected to be completed by September 19, 2025, represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation, allowing the woman-owned small business to compete directly in the federal pharmaceutical procurement market. Performance will take place at the company's headquarters in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that has served as a critical supplier to the Defense Logistics Agency since the early 2000s, with a substantial $499.99 billion IDC vehicle valid through November 2026. This delivery order for yellow fever vaccine vials supports the medical supply needs of Department of Defense healthcare facilities and reflects the company's consistent role in distributing vaccines, biologics, and other pharmaceutical products to military health systems. The firm's federal procurement portfolio demonstrates extensive experience delivering specialized pharmaceutical products ranging from prescription medications to vaccines and injections across military healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/28/25 |